Daxor Corporation announces the expansion of its blood volume analysis, BVA, technology through the acquisition of the BVA analyzer. This advancement not only enhances revenue streams, but also sets the stage for projected accelerated sales growth for the rest of the year. A rural 339-bed community hospital in northwest Mississippi, part of the Mid-South’s largest integrated delivery network, has acquired a BVA analyzer for outpatient heart failure care. This acquisition is critical for enhancing patient outcomes in a region where access to specialized care can be limited.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXR:
- Daxor Corporation Announces Launch of BVA Program at Mid-South Largest Integrated Network
- Daxor awarded $1.9M contract by the U.S. Air Force
- Daxor expands blood volume analysis in three new facilities
- Daxor Expands To Three New Facilities As Blood Volume Analysis Technology Gains Momentum Nationwide
- Daxor awarded $550K matching-fund extension from U.S. DHA